AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Vglip M Tablet SR

Prescription Icon
Prescription Required

Marketer

Bio Schutz Pharmaceuticals Pvt Ltd

Salt Composition

Metformin (500mg) + Vildagliptin (50mg)

Overview Vglip M Tablet SR

Diabetic patients with type 2 mellitus may find relief from elevated blood glucose levels with Vglip M Tablet SR, a dual-action medication. This formulation helps mitigate severe diabetic complications like renal impairment and vision loss, potentially lowering the risk of cardiovascular events. Vglip M Tablet SR may be used independently or in conjunction with other antidiabetic agents. Optimal therapeutic outcomes require adherence to a balanced diet and regular physical activity. Dosage is tailored to individual needs, factoring in health status, glycemic control, and other concurrent medications. Consuming this medication with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes efficacy; discontinuation should only occur under medical supervision. This treatment aims to manage blood sugar and reduce long-term complications. Continued commitment to the physician-recommended diet and exercise plan is vital for effective diabetes management, as lifestyle plays a crucial role in disease control. Commonly reported side effects encompass diarrhea, nausea, vomiting, dyspepsia, cephalalgia, pharyngitis, asthenia, GERD, hyperhidrosis, and anorexia. Hypoglycemia is a potential adverse effect when used with insulin or sulfonylureas; understanding its symptoms and management is essential. This medication isn't universally suitable. Prior to commencing treatment, individuals with pre-existing kidney, liver, or heart conditions, pancreatic disorders, or significant alcohol consumption should consult their physician. Pregnant or lactating women should also seek medical advice. Drug interactions are possible; disclose all medications to your doctor to ensure treatment safety. Alcohol should be limited due to its potential to lower blood glucose. Kidney function and blood glucose levels are monitored by your doctor throughout the treatment period.

Uses of Vglip M Tablet SR

Managing Type 2 Diabetes

Major Benefits of Vglip M Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Vglip M Tablet SR should be administered with a meal.

Common Side effects of Vglip M Tablet SR:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Vglip M Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Vglip M Tablet SR should be administered with a meal.

How Vglip M Tablet SR works:

Vglip M Extended-Release Tablets contain a dual-action formulation for diabetes management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol ingestion and Vglip M Tablet SR is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Vglip M Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Vglip M tablets are likely not safe for use while breastfeeding. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with impaired kidney function should exercise caution when using Vglip M Tablet SR. A modified dosage of Vglip M Tablet SR may be necessary; physician consultation is advised.

LiverLiverUNSAFE

Use of Vglip M Tablet SR is potentially hazardous for individuals with hepatic impairment and is best avoided. Seek medical advice.

What if you forget to take Vglip M Tablet SR :

Should you forget a dose of Vglip M Tablet SR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.

Facts to Know About Vglip M Tablet SR

LabelValue
Developing Good Habits No.
Treatment Category Diabetes Management

FAQs on Vglip M Tablet SR

Vglip M Tablet SR typically doesn't cause low blood sugar (hypoglycemia) by itself. However, hypoglycemia can occur if you don't consume enough calories while using it. Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, and shakiness. These are more likely if you skip meals, drink alcohol, overexert yourself, or take other diabetes medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Nausea and vomiting are possible side effects of Vglip M Tablet SR. If vomiting occurs, sip small amounts of water or other fluids frequently. Consult your doctor if vomiting continues or you experience dehydration symptoms such as dark, strong-smelling urine and infrequent urination. Always discuss taking other medications with your doctor.
Patients with allergies to Vglip M Tablet SR components or excipients, or those suffering from severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis, should not use this medication.
Store this medication in its original, tightly closed container, as directed on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Vglip M SR tablets combine the anti-diabetic medications metformin (a biguanide) and vildagliptin. Metformin reduces liver glucose production, slows intestinal glucose absorption, and improves insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This combination is contraindicated in individuals under 18.
Vglip M Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect necessitates avoidance in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. Seek immediate medical attention, including discontinuing Vglip M Tablet SR, if these symptoms occur.
Prolonged Vglip M Tablet SR use can lead to Vitamin B12 deficiency by hindering its absorption in the stomach, potentially resulting in anemia and neurological complications if left untreated.
Vglip M Tablet SR is safe when used as directed by your doctor. Even with proper usage, you may experience side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, or low blood sugar (hypoglycemia, especially if combined with insulin or sulfonylurea). Report any persistent side effects to your doctor.
Vglip M Tablet SR
85
MRP 98
13% off